πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 112 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7722865

Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses the

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7612073

Methods of administering tetrahydrobiopterin, associated compositions, and methods of meas

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7601717

Pterin analogs

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566462

Stable tablet formulation

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566714

Methods and compositions for the treatment of metabolic disorders

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7560263

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer usi

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7553653

Variants and chemically-modified variants of phenylalanine ammonia-lyase

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7537923

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer usi

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7534595

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7531341

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7442372

Delivery of therapeutic compounds to the brain and other tissues

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354576

Methods of treating diseases caused by deficiencies of recombinant Ξ±-L-iduronidase

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7264799

Use of heparinases to decrease inflammatory response

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6972124

Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Dec 06 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6866844

Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and me

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Mar 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6569661

Recombinant &agr;-L-iduronidase, methods for producing and purifying the same and methods

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 27 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired